Content about Lobbying

May 13, 2013

The Generic Pharmaceutical Association has promoted Jason Money to associate VP federal government affairs, the trade group said Monday.

WASHINGTON — The Generic Pharmaceutical Association has promoted Jason Money to associate VP federal government affairs, the trade group said Monday.

Money, who has worked for the GPhA for six years, was previously the organization's senior director for federal affairs. In the new position, he will continue lobbying on behalf of the generic drug industry in Congress.

January 23, 2013

A lobbying organization for independent pharmacies has launched an ad campaign in The Hill, the Washington-based daily newspaper covering Congress.

ALEXANDRIA, Va. — A lobbying organization for independent pharmacies has launched an ad campaign in The Hill, the Washington-based daily newspaper covering Congress.

The National Community Pharmacists Association ad lays out the group's legislative agenda for the 113th Congress and the Obama administration.

November 24, 2010

Most of the newly elected and re-elected Republican members of Congress, Tea Party candidates in particular, vowed to whittle down or repeal healthcare reform once in office, but the healthcare companies that stand to benefit hope to change their minds, as some of their lobbying activities last quarter have shown.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Most of the newly elected and re-elected Republican members of Congress, Tea Party candidates in particular, vowed to whittle down or repeal healthcare reform once in office, but the healthcare companies that stand to benefit hope to change their minds, as some of their lobbying activities last quarter have shown.

(THE NEWS: Report: PhRMA's lobbying efforts total more than $5 million in Q3. For the full story, click here)

November 22, 2010

The pharmaceutical lobby spent more than $5 million lobbying the government during the third quarter ...

NEW YORK The pharmaceutical lobby spent more than $5 million lobbying the government during the third quarter, according to published reports.

Based on a filing with the government, BusinessWeek reported that the Pharmaceutical Research and Manufacturers of America spent $5.2 million lobbying on issues ranging from healthcare legislation to drug importation and marketing.

This compared with $6.8 million in third quarter 2009, according to the magazine.